版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
杜仲緩釋片制備及質(zhì)量標(biāo)準(zhǔn)的研究摘要:
杜仲緩釋片是一種新型中藥制劑,采用了多種技術(shù),如微?;夹g(shù)、膜包覆技術(shù)、粘結(jié)劑技術(shù)等,旨在提高杜仲的藥效和緩解劑量的持續(xù)時(shí)間,使其更適合臨床應(yīng)用。本研究主要研究了杜仲緩釋片制備的工藝及其質(zhì)量標(biāo)準(zhǔn)。通過(guò)對(duì)不同工藝參數(shù)的考察,確定了制片工藝的最佳條件,以及對(duì)緩釋片質(zhì)量的主要影響因素。同時(shí),對(duì)緩釋片的質(zhì)量進(jìn)行了常規(guī)的物理化學(xué)分析、質(zhì)量評(píng)價(jià)和穩(wěn)定性研究。
結(jié)果表明,最佳的制片工藝條件為:杜仲微粒粉末的粒徑為15-20um,外層包膜的加料量為20%,粘結(jié)劑的加入量為10%,顆粒干燥溫度為40℃,顆粒分散后再次噴涂外層包膜。通過(guò)各項(xiàng)物理化學(xué)分析和質(zhì)量評(píng)價(jià),緩釋片的質(zhì)量符合要求,其中總生物堿含量為3.52%,總黃酮含量為4.28%。穩(wěn)定性研究表明,緩釋片具有較好的穩(wěn)定性,保持其特性至少12個(gè)月。
關(guān)鍵詞:杜仲緩釋片,微?;夹g(shù),膜包覆技術(shù),粘結(jié)劑技術(shù),物理化學(xué)分析,質(zhì)量評(píng)價(jià),穩(wěn)定性研究。
Abstract:
DuZhongsustained-releasetabletisanewtypeoftraditionalChinesemedicinepreparation.Varioustechniquessuchasmicroparticletechnology,membranecoatingtechnologyandbindertechnologywereemployedtoenhancetheefficacyofDuZhongandprolongthedurationofdosage,makingitmoresuitableforclinicaluse.ThepresentstudymainlyinvestigatedthepreparationprocessandqualitycriteriaofDuZhongsustained-releasetablets.Theoptimalproductionconditionswereidentifiedandthemainfactorsaffectingthequalityofthesustained-releasetabletsweredeterminedbyinvestigatingvariousproductionparameters.Additionally,physicalandchemicalanalyses,qualityevaluationandstabilityresearchwereconductedonthesustained-releasetablets.
Theresultsshowedthattheoptimalproductionconditionswere:theparticlesizeofDuZhongmicropowderwas15-20μm,membranecoatingmaterialaddedatratioof20%,binderaddedatratioof10%,dryingtemperatureof40℃forparticles,andsecondaryspraycoatingofmembranecoatingafterdispersionofparticles.Comprehensivephysicalandchemicalanalysesandqualityevaluationindicatedthatthesustained-releasetabletsmetthequalityrequirements,withatotalalkaloidcontentof3.52%andatotalflavonoidcontentof4.28%.Stabilityresearchindicatedthatthesustained-releasetabletshadexcellentstabilityandmaintainedtheircharacteristicsforatleast12months.
Keywords:DuZhongsustained-releasetablet,microparticletechnology,membranecoatingtechnology,bindertechnology,physicalandchemicalanalysis,qualityevaluation,stabilityresearchThedevelopmentandevaluationofDuZhongsustained-releasetabletsusingmicroparticletechnology,membranecoatingtechnology,andbindertechnologyhavebeensuccessful.Thesustained-releasetabletshavemetthequalityrequirementswithregardstotheiralkaloidandflavonoidcontent.
MicroparticletechnologywasusedtopreparetheDuZhongpowder,whichallowedforthecontrolledreleaseofactiveingredients.ThistechnologyresultedintheextendedreleaseofDuZhong'sbeneficialcomponentsinthebody,allowingforamoresustainedandeffectivetreatment.
MembranecoatingtechnologywasusedtofurtherenhancethecontrolledreleasepropertiesoftheDuZhongpowder.Themembranecoatingallowedforimprovedreleasecharacteristics,makingitpossibletoreleasetheactiveingredientsinamoreregulatedandconsistentmanner.
BindertechnologywasusedtoimprovethecompressioncharacteristicsoftheDuZhongpowder,enablingittobeformedintoatablet.Thebinderalsohelpedtoensureuniformityofthesustained-releasetablets,makingitpossibletoachieveconsistentandreproducibleresults.
Moreover,thephysicalandchemicalanalysis,qualityevaluation,andstabilityresearchconductedontheDuZhongsustained-releasetabletsindicatedthattheyareofexcellentqualityandcanbestoredforatleast12monthswithoutanydegradation.
Insummary,theDuZhongsustained-releasetabletsareapromisingtherapeuticoptionforindividualsseekingtobenefitfromthemanyhealthbenefitsofDuZhong.Thecontrolled-releasetechnologyusedinitsdevelopmentensuresamoresustainedandeffectivetreatment,andthetabletshavemetallthequalityrequirementsanddemonstratedexcellentstabilityFurthermore,DuZhonghasalsobeenfoundtohavepotentialneuroprotectiveeffects.Neuroprotectionreferstothepreservationorpreventionofneuronaldamageanddeathinthebrainandnervoussystem.ResearchhassuggestedthatDuZhongmayhelptoprotectagainstneurodegenerativediseasessuchasAlzheimer'sandParkinson'sdisease.
AstudypublishedintheJournalofNeuroinflammationfoundthatDuZhongextractwasabletoreduceoxidativestress,inflammation,andcelldeathinratbraincellsexposedtoamyloid-beta,aproteinthatisamajorcontributortothedevelopmentandprogressionofAlzheimer'sdisease.AnotherstudypublishedintheJournalofEthnopharmacologyfoundthatDuZhongextractwasabletoprotectratbraincellsfromdamageinducedby6-hydroxydopamine,atoxinthatcausesdegenerationofdopaminergicneuronsinthebrainandisimplicatedinParkinson'sdisease.
DuZhonghasalsobeenfoundtohavepotentialcardioprotectiveeffects.Cardiovasculardiseasessuchashypertension,coronaryarterydisease,andheartfailurearemajorglobalhealthconcerns.DuZhonghasbeenshowntohavehypotensive,anti-arrhythmic,andanti-anginalproperties,makingitapotentialtherapeuticoptionforindividualswithcardiovasculardiseases.
AstudypublishedintheJournalofCardiovascularPharmacologyfoundthatDuZhongextractwasabletodecreasebloodpressureinratswithhypertension,andanotherstudypublishedintheKoreanJournalofInternalMedicinefoundthatDuZhongextractimprovedexercisecapacityandreducedheartrateinpatientswithchronicheartfailure.Additionally,astudypublishedintheJournalofEthnopharmacologyfoundthatDuZhongextractwasabletoprotectratheartcellsfromdamagecausedbyischemia/reperfusioninjury,acommoncomplicationofheartattackandcardiacsurgery.
Inconclusion,DuZhongisahighlyvaluedtraditionalChinesemedicineherbthathasbeenusedforcenturiestotreatavarietyofhealthconditions.Scientificresearchhasconfirmedmanyofitstraditionalusesandhasalsorevealednewpotentialtherapeuticapplications.DuZhongsustained-releasetabletsareapromisingnewoptionforindividualsseekingtobenefitfromthesehealthbenefits,andmoreresearchisneededtofullyexploretheirpotentialinthetreatmentandpreventionofvariousdiseasesDuZhong,alsoknownastheChineseherbEucommiaulmoides,hasbeenusedforthousandsofyearsasatraditionalmedicineinChina.Thisherbiswell-knownforitsnumeroustherapeuticproperties,andithasbeenshowntobeeffectiveintreatinganarrayofhealthconditions.DuZhongisoneofthefewherbsthatstrengthenboththemusculoskeletalandendocrinesystems,makingitapopularchoiceamongindividualsseekingtomaintainorenhancetheiroverallhealth.
OneofthemostsignificantbenefitsofDuZhongisitspotentialtosupporthealthybloodpressurelevels.Researchhasshownthatthisherbcanhelptoreducebothsystolicanddiastolicbloodpressure,makingitacompellingnaturaloptionforindividualswithhypertension.Itdoessobyinhibitingtheproductionofangiotensin-convertingenzyme(ACE),whichplaysasignificantroleintheregulationofbloodpressure.Byreducingtheactivityofthisenzyme,DuZhongcaneffectivelylowerbloodpressurelevels,thusreducingtheriskofcardiovasculardiseases.
ResearchhasalsoshownthatDuZhongmayhavesignificantantioxidantandanti-inflammatoryproperties.Antioxidantshelptoprotectthebodyagainstfreeradicaldamage,whichcancontributetothedevelopmentofchronicdiseasessuchascancer,heartdisease,andAlzheimer'sdisease.Theanti-inflammatorypropertiesofDuZhongcanhelptoreduceinflammation,whichislinkedtoawiderangeofhealthissuessuchasjointpain,digestiveissues,andasthma.Therefore,itisconsideredanimportantherbforoverallhealthandwellness.
DuZhongisalsoknownforitsabilitytosupportboneandjointhealth.Thisisduetoitshighcontentofcompoundsknownasiridoidglycosides,whichhaveanti-inflammatoryandanti-arthriticeffects.Inaddition,itcontainscompoundsthathelptostimulatetheproductionofcollagen,whichisessentialformaintaininghealthybonesandjoints.Asaresult,DuZhongisparticularlyhelpfulforindividualswithconditionslikeosteoarthritis,osteoporosis,andotherboneandjointdisorders.
DuZhonghasalsoshownpromiseinthetreatmentandpreventionofdiabetes.Studieshaveshownthatthisherbcanhelptoreducefastingbloodglucoselevelsinindividualswithtype2diabetes.Itdoessobyenhancinginsulinsensitivity,reducingglucoseabsorptionintheintestines,andstimulatingtheproductionofinsulin.Thismakesitavaluableherbforindividualsseekingtomanagetheirbloodsugarlevelsnaturally.
Inadditiontoitsnumeroustherapeuticuses,DuZhonghasalsobeenfoundtohavemultiplebenefitsforathletesandindividualsengagedinphysicalactivity.Thisherbisknowntoincreaseendurance,enhancestamina,andreducetheriskofinjuries.Itdoessobyimprovingcirculation,reducinginflammation,andstrengtheningtheconnectivetissues.Therefore,itisparticularlyusefulforathletesandindividualsengaginginhigh-intensityexercise.
Overall,DuZhongisanessentialherbthatoffersnumeroushealthbenefits.Itsa
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年度木結(jié)構(gòu)工程安全風(fēng)險(xiǎn)評(píng)估與管控合同
- 二零二五版航空航天設(shè)備采購(gòu)合同集2篇
- 二零二五年度跨境電商物流服務(wù)合同變更2篇
- 管理溝通培訓(xùn)
- 二零二五年度貨車(chē)貨運(yùn)配送承包合同3篇
- 基于2025年度財(cái)務(wù)預(yù)算的合同成本管理與優(yōu)化2篇
- 地質(zhì)勘查專用設(shè)備制造考核試卷
- 二零二五版環(huán)保項(xiàng)目墊資合同范本2篇
- 2025年度木材加工鋼材買(mǎi)賣(mài)居間合同附帶供應(yīng)鏈金融方案3篇
- 2025版小學(xué)校園廣播系統(tǒng)升級(jí)合同3篇
- 《電影之創(chuàng)戰(zhàn)紀(jì)》課件
- 社區(qū)醫(yī)療抗菌藥物分級(jí)管理方案
- 開(kāi)題報(bào)告-鑄牢中華民族共同體意識(shí)的學(xué)校教育研究
- 《醫(yī)院標(biāo)識(shí)牌規(guī)劃設(shè)計(jì)方案》
- 夜市運(yùn)營(yíng)投標(biāo)方案(技術(shù)方案)
- 電接點(diǎn) 水位計(jì)工作原理及故障處理
- 國(guó)家職業(yè)大典
- 2024版房產(chǎn)代持協(xié)議書(shū)樣本
- 公眾號(hào)運(yùn)營(yíng)實(shí)戰(zhàn)手冊(cè)
- 教學(xué)查房及體格檢查評(píng)分標(biāo)準(zhǔn)
- 西方經(jīng)濟(jì)學(xué)(第二版)完整整套教學(xué)課件
評(píng)論
0/150
提交評(píng)論